These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6293990)

  • 61. Myasthenia gravis.
    De Baets MH
    Year Immunol; 1989-1990; 6():269-75. PubMed ID: 2701909
    [No Abstract]   [Full Text] [Related]  

  • 62. Effect of myasthenic immunoglobulin G on motor end-plate morphology.
    Tsujihata M; Satoh A; Yoshimura T; Motomura M; Takeo G; Matsuo H; Nakamura T
    J Neurol; 2003 Jan; 250(1):75-82. PubMed ID: 12527996
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Animal models of myasthenia gravis].
    Shigemoto K; Takashima R; Motohashi N; Mori S
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():97-104. PubMed ID: 26480686
    [No Abstract]   [Full Text] [Related]  

  • 64. Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice.
    Vassilev T; Yamamoto M; Aissaoui A; Bonnin E; Berrih-Aknin S; Kazatchkine MD; Kaveri SV
    Eur J Immunol; 1999 Aug; 29(8):2436-42. PubMed ID: 10458757
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Purification of high-affinity Fab fragments from experimental autoimmune myasthenia gravis rabbits and their effect on isolated acetylcholine receptors.
    Mihovilovic M; Martinez-Carrion M
    Biochemistry; 1979 Oct; 18(21):4522-8. PubMed ID: 497153
    [No Abstract]   [Full Text] [Related]  

  • 66. Increased uptake of acetylcholine-receptor antibody at motor endplate in myasthenic exacerbation.
    de Crousaz G; Fulpius BW
    Lancet; 1978 Jan; 1(8054):47. PubMed ID: 74528
    [No Abstract]   [Full Text] [Related]  

  • 67. Myasthenia gravis and primary biliary cirrhosis. Common immunological features and rare coincidence.
    Kiechl S; Kohlendorfer U; Willeit J; Pohl P; Vogel W
    Acta Neurol Scand; 1996 Apr; 93(4):263-5. PubMed ID: 8739436
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acquired myasthenia gravis.
    Massey JM
    Neurol Clin; 1997 Aug; 15(3):577-95. PubMed ID: 9227954
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.
    Toyka KV; Löwenadler B; Heininger K; Besinger UA; Birnberger KL; Fateh-Moghadam A; Heilbronn E
    J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):836-42. PubMed ID: 6252294
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Leukoplasmapheresis for myasthenia gravis. Acetylcholine receptor antibody production.
    Seybold ME; Tsoukas C; Lindstrom J; Fong S; Vaughan J
    Arch Neurol; 1982 Jul; 39(7):433-5. PubMed ID: 6980639
    [No Abstract]   [Full Text] [Related]  

  • 71. Experimental neonatal autoimmune myasthenia gravis: an immunohistochemical, ultrastructural and electrophysiological study of the motor end-plate.
    Tetsuo N; Tsujihata M; Satoh A; Yoshimura T; Nakamura T; Seto M; Nagataki S
    J Neurol Sci; 1995 Oct; 132(2):97-104. PubMed ID: 8543956
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ultrastructure of motor endplates in canine congenital myasthenia gravis.
    Wilkes MK; McKerrell RE; Patterson RC; Palmer AC
    J Comp Pathol; 1987 May; 97(3):247-56. PubMed ID: 3611429
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ultrastructural localization of acetylcholine receptor at the motor endplate: myasthenia gravis and other neuromuscular diseases.
    Tsujihata M; Hazama R; Ishii N; Ide Y; Takamori M
    Neurology; 1980 Nov; 30(11):1203-11. PubMed ID: 7191515
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Paucity of secondary synaptic clefts in a case of congenital myasthenia with multiple contractures: ultrastructural morphology of a developmental disorder.
    Smit LM; Jennekens FG; Veldman H; Barth PG
    J Neurol Neurosurg Psychiatry; 1984 Oct; 47(10):1091-7. PubMed ID: 6094728
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Limb muscle endplates in ocular myasthenia gravis: quantitative ultrastructural study.
    Tsujihata M; Hazama R; Ishii N; Ide Y; Mori M; Takamori M
    Neurology; 1979 May; 29(5):654-61. PubMed ID: 571563
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis.
    Bond A; Corlett L; Nagvekar N; Jacobson L; Pantic N; Beeson D; Nicolle M; Vincent A; Newsom-Davis J; Spack E; Willcox N
    Biochem Soc Trans; 1997 May; 25(2):665-70. PubMed ID: 9191178
    [No Abstract]   [Full Text] [Related]  

  • 77. [Auto-immune diseases of the skeletal muscle-system. Immune-pathogenetic mechanisms in myasthenia gravis and polymyositis (author's transl)].
    Kalden JR
    Immun Infekt; 1975 Jul; 3(3):100-15. PubMed ID: 1184099
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human disease transferred to mice: myasthenia gravis.
    Dawson DM
    N Engl J Med; 1977 Jan; 296(3):168-9. PubMed ID: 831078
    [No Abstract]   [Full Text] [Related]  

  • 79. Specific immunosorbents in diagnosis and management of myasthenia gravis.
    Maelicke A; Yang BH; Sundaram PV; Fels G
    Ann N Y Acad Sci; 1987; 505():669-75. PubMed ID: 3318622
    [No Abstract]   [Full Text] [Related]  

  • 80. The developmental change in immunological properties of the acetylcholine receptor in rat muscle.
    Reiness CG; Hall ZW
    Dev Biol; 1981 Jan; 81(2):324-31. PubMed ID: 6162693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.